Funding Rounds
Laverock Therapeutics

Laverock Therapeutics Seed (2023, $16M)

Laverock Therapeutics

Gene silencing platform for the creation of programmable, allogeneic cell therapies.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $16.38M

Investors